Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze T H
Department of Physiology, New York Medical College, Valhalla 10595, USA.
Circulation. 1995 May 15;91(10):2655-63. doi: 10.1161/01.cir.91.10.2655.
Activation in conscious dogs of the carotid chemoreflex or cardiac receptors results in coronary vasodilation that is mediated by a vagal cholinergic mechanism. Our previous study showed that the coronary vasodilation following activation of carotid chemoreflex is also mediated by nitric oxide (NO). In addition, NO production is depressed after the development of heart failure. Therefore, we hypothesized that the coronary vasodilation after activation of reflexes that elicit efferent vagal coronary vasodilation would be blunted in conscious dogs after pacing-induced heart failure due to the disappearance of NO.
Mongrel dogs were chronically instrumented using sterile techniques for measurements of systemic hemodynamics and left circumflex coronary blood flow (CBF). Without the heart rate controlled, intra-atrial injection of veratrine (4 micrograms/kg) caused bradycardia (-36 +/- 3 beats per minute). With the heart rate controlled, veratrine increased CBF in a dose-dependent manner: for example, 4 micrograms/kg of veratrine increased CBF by 54 +/- 5% from 38 +/- 4.9 mL/min (P < .05). The increases in CBF induced by veratrine were markedly blunted by nitro-L-arginine (NLA). Activation of carotid chemoreflex by nicotine increased CBF by 121 +/- 9% from 32 +/- 4 mL++/min (P < .05) with the heart rate controlled and caused bradycardia (-32 +/- 5 beats per minute) without the heart rate controlled. After the development of heart failure, in response to activation of carotid chemoreflex or cardiac receptors the coronary vasodilation was almost abolished (CBF increased by only 23 +/- 8% or 11 +/- 3%, P < .05 compared with control). There still was a marked bradycardia after injections of nicotine or veratrine (-50 +/- 11 or -48 +/- 7 beats per minute).
Our results indicate that vagally mediated coronary vasodilation is selectively attenuated in conscious dogs after pacing-induced heart failure, whereas the vagally mediated bradycardia is preserved. Since muscarinic receptor-induced coronary vasodilation is mediated by NO, the disappearance of NO from blood vessels leads to a defect in the integrated neural regulation of coronary blood flow and myocardial function during heart failure.
清醒犬的颈动脉化学反射或心脏感受器激活可导致冠状动脉扩张,这是由迷走胆碱能机制介导的。我们之前的研究表明,颈动脉化学反射激活后的冠状动脉扩张也由一氧化氮(NO)介导。此外,心力衰竭发生后NO生成减少。因此,我们推测,由于NO消失,起搏诱导的心力衰竭后清醒犬中,引发传出迷走神经介导的冠状动脉扩张的反射激活后的冠状动脉扩张会减弱。
使用无菌技术对杂种犬进行长期仪器植入,以测量全身血流动力学和左旋冠状动脉血流量(CBF)。在未控制心率的情况下,心房内注射藜芦碱(4微克/千克)导致心动过缓(每分钟-36±3次心跳)。在控制心率的情况下,藜芦碱以剂量依赖方式增加CBF:例如,4微克/千克的藜芦碱使CBF从38±4.9毫升/分钟增加54±5%(P<.05)。硝基-L-精氨酸(NLA)显著减弱了藜芦碱诱导的CBF增加。在控制心率的情况下,尼古丁激活颈动脉化学反射使CBF从32±4毫升/分钟增加121±9%(P<.05),在未控制心率的情况下导致心动过缓(每分钟-32±5次心跳)。心力衰竭发生后,对颈动脉化学反射或心脏感受器激活的反应中,冠状动脉扩张几乎消失(CBF仅增加23±8%或11±3%,与对照组相比P<.05)。注射尼古丁或藜芦碱后仍有明显心动过缓(每分钟-50±11次或-48±7次心跳)。
我们的结果表明,起搏诱导的心力衰竭后清醒犬中,迷走神经介导的冠状动脉扩张选择性减弱,而迷走神经介导的心动过缓得以保留。由于毒蕈碱受体诱导的冠状动脉扩张由NO介导,血管中NO的消失导致心力衰竭期间冠状动脉血流和心肌功能的整合神经调节出现缺陷。